156 related articles for article (PubMed ID: 30733684)
1. Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma.
Waly AA; El-Ekiaby N; Assal RA; Abdelrahman MM; Hosny KA; El Tayebi HM; Esmat G; Breuhahn K; Abdelaziz AI
Front Physiol; 2018; 9():1918. PubMed ID: 30733684
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
[TBL] [Abstract][Full Text] [Related]
3. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
5. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
6. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
7. Let-7a regulation of insulin-like growth factors in breast cancer.
Lu L; Katsaros D; Zhu Y; Hoffman A; Luca S; Marion CE; Mu L; Risch H; Yu H
Breast Cancer Res Treat; 2011 Apr; 126(3):687-94. PubMed ID: 20848182
[TBL] [Abstract][Full Text] [Related]
8. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
9. Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression.
Xue F; Liu Y; Zhang H; Wen Y; Yan L; Tang Q; Xiao E; Zhang D
Onco Targets Ther; 2016; 9():7253-7261. PubMed ID: 27932893
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA let-7a and let-7f as novel regulatory factors of the sika deer (Cervus nippon) IGF-1R gene.
Hu W; Li T; Hu R; Wu L; Li M; Meng X
Growth Factors; 2014 Feb; 32(1):27-33. PubMed ID: 24294913
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy.
Liu YM; Xia Y; Dai W; Han HY; Dong YX; Cai J; Zeng X; Luo FY; Yang T; Li YZ; Chen J; Guan J
BMC Cancer; 2014 Nov; 14():889. PubMed ID: 25429777
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
13. Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.
Habashy DA; El Tayebi HM; Fawzy IO; Hosny KA; Esmat G; Abdelaziz AI
World J Hepatol; 2016 Aug; 8(23):976-84. PubMed ID: 27621763
[TBL] [Abstract][Full Text] [Related]
14. LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis.
Lu L; Katsaros D; Canuto EM; Biglia N; Risch HA; Yu H
Gynecol Oncol; 2016 Apr; 141(1):121-7. PubMed ID: 26751131
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression.
Liu C; Chen Z; Fang M; Qiao Y
Transl Cancer Res; 2019 Sep; 8(5):1763-1771. PubMed ID: 35116927
[TBL] [Abstract][Full Text] [Related]
17. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor.
Yang S; Tang W; He Y; Wen L; Sun B; Li S
Cell Death Dis; 2018 Jan; 9(2):99. PubMed ID: 29367587
[TBL] [Abstract][Full Text] [Related]
19. LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11.
Yang L; Si H; Ma M; Fang Y; Jiang Y; Wang J; Zhang C; Xiao H
Cancer Cell Int; 2021 Apr; 21(1):202. PubMed ID: 33836753
[TBL] [Abstract][Full Text] [Related]
20. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
